Hussein Chehade

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Breast Cancer Risk

Ankylosing Spondylitis

Bioinformatics Analysis

Top Venues

Cancer research communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Hussein Chehade, Radhika P Gogoi, Nicholas K Adzibolosu, Sandra Galoforo, Rouba-Ali Fehmi, Mira Kheil, Alexandra Lucienne Fox, Seongho Kim, Ramandeep Rattan, Zhanjun Hou, Robert T Morris, Larry H Matherly, Gil Mor, Ayesha B Alvero
BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer. Cancer research communications 4 (8) (2024)
Hussein Chehade, Radhika P Gogoi, Nicholas K Adzibolosu, Sandra Galoforo, Rouba-Ali Fehmi, Mira Kheil, Alexandra Lucienne Fox, Seongho Kim, Ramandeep Rattan, Zhanjun Hou, Robert T Morris, Larry H Matherly, Gil Mor, Ayesha B Alvero
BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer. Cancer research communications 4 (8) (2024)
Hussein Chehade, Radhika P Gogoi, Nicholas K Adzibolosu, Sandra Galoforo, Rouba-Ali Fehmi, Mira Kheil, Alexandra Lucienne Fox, Seongho Kim, Ramandeep Rattan, Zhanjun Hou, Robert T Morris, Larry H Matherly, Gil Mor, Ayesha B Alvero
BRCA status dictates Wnt responsiveness in epithelial ovarian cancer. Cancer research communications (2024)
Hussein Chehade, Radhika P Gogoi, Nicholas K Adzibolosu, Sandra Galoforo, Rouba-Ali Fehmi, Mira Kheil, Alexandra Lucienne Fox, Seongho Kim, Ramandeep Rattan, Zhanjun Hou, Robert T Morris, Larry H Matherly, Gil Mor, Ayesha B Alvero
BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer. Cancer research communications 4 (8) (2024)
Ayesha B Alvero, Alexandra Lucienne Fox, Bhaskara Reddy Madina, Marie M Krady, Radhika P Gogoi, Hussein Chehade, Valerian Nakaar, Bijan Almassian, Timur O Yarovinsky, Thomas Rutherford, Gil Mor
Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory. Cancer immunology research (2023)